Friday, August 06, 2021 8:43:08 AM
BYSI
New York Yankees and Duke Basketball
Recent BYSI News
- BeyondSpring R&D Day Highlights New Plinabulin Development Strategy for Cancer and Updates for SEED Therapeutics • GlobeNewswire Inc. • 05/16/2024 12:00:00 PM
- BeyondSpring To Host Virtual R&D Day to Discuss New Plinabulin Development Strategy for Cancer and Updates for SEED Therapeutics • GlobeNewswire Inc. • 05/03/2024 11:00:00 AM
- BeyondSpring Provides Business Update and Reports Year End 2023 Financial Results • GlobeNewswire Inc. • 04/29/2024 09:30:00 PM
- BeyondSpring Files 2023 Annual Report on Form 20-F • GlobeNewswire Inc. • 04/29/2024 09:30:00 PM
- BeyondSpring Announces First Patient Dosed with Pembrolizumab, Plinabulin Plus Etoposide/Platinum in a Phase 2 Investigator-initiated Study of First-Line Extensive-Stage Small-Cell Lung Cancer • GlobeNewswire Inc. • 03/25/2024 11:00:00 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 02/26/2024 01:01:19 PM
- BeyondSpring Regains Compliance with Nasdaq Minimum Bid Price and Periodic Filing Requirements • GlobeNewswire Inc. • 02/26/2024 01:00:00 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/14/2024 09:30:59 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 02/02/2024 09:30:32 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 01/16/2024 09:30:13 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 01/10/2024 08:00:38 PM
- BeyondSpring Receives Nasdaq Delinquency Notice Regarding Late Filing of Its Form 6-K • GlobeNewswire Inc. • 01/10/2024 08:00:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 12/18/2023 09:31:23 PM
- BeyondSpring Receives Nasdaq Notice Regarding Minimum Bid Price Requirements • GlobeNewswire Inc. • 12/18/2023 09:30:00 PM
- BeyondSpring Presents Poster Highlighting Preclinical and Clinical POC Immunomodulating Activity of Plinabulin Inducing Dendritic Cell Maturation and Re-sensitization in Immunotherapy Refractory Tumors when Combined with Radiation and PD-1/PD-L1 Inhibitors • GlobeNewswire Inc. • 11/07/2023 12:00:00 PM
- BeyondSpring and Professor K. Eisenmann of the University of Toledo College of Medicine Present Poster Highlighting Plinabulin’s Anti-cancer Efficacy in Primary and Recurrent Glioblastoma Patient Derived Invasive Neurosphere Models • GlobeNewswire Inc. • 10/31/2023 12:00:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 10/30/2023 12:05:19 PM
- BeyondSpring Regains Compliance with Nasdaq Minimum Bid Price Requirement • GlobeNewswire Inc. • 10/30/2023 12:00:00 PM
- SEED Therapeutics Discloses Novel Molecular Glue IND Candidate for Cancer at “Targeted Protein Degradation Think Tank” Symposium • GlobeNewswire Inc. • 10/26/2023 12:30:00 PM
- SEED Therapeutics, a BeyondSpring Subsidiary, Appoints Mr. Ko-Yung Tung to the Board of Directors • GlobeNewswire Inc. • 10/23/2023 11:45:00 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 10/04/2023 08:00:38 PM
- BeyondSpring Receives Nasdaq Notice Regarding Minimum Bid Price Requirements • GlobeNewswire Inc. • 10/04/2023 07:55:00 PM
- BeyondSpring and Leading Cancer Center to Present Poster at SITC’s 38th Annual Meeting • GlobeNewswire Inc. • 09/27/2023 02:00:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 09/20/2023 09:20:19 PM
- BeyondSpring to Participate in the R.W. Baird’s 2023 Global Healthcare Conference • GlobeNewswire Inc. • 09/07/2023 12:00:00 PM
FEATURED Music Licensing, Inc. (OTC: SONG) Subsidiary Pro Music Rights Secures Final Judgment of $114,081.30 USD, Demonstrating Strength of Licensing Agreements • May 17, 2024 11:00 AM
Greenlite Ventures Inks Deal to Acquire No Limit Technology • GRNL • May 17, 2024 3:00 PM
VPR Brands (VPRB) Reports First Quarter 2024 Financial Results • VPRB • May 17, 2024 8:04 AM
ILUS Provides a First Quarter Filing Update • ILUS • May 16, 2024 11:26 AM
Cannabix Technologies and Omega Laboratories Inc. enter Strategic Partnership to Commercialize Marijuana Breathalyzer Technology • BLO • May 16, 2024 8:13 AM
Avant Technologies to Revolutionize Data Center Management with Proprietary AI Software Platform • AVAI • May 16, 2024 8:00 AM